Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases

The Beijing/W genotype is one of the major molecular families of <i>Mycobacterium tuberculosis</i> complex (MTBC), responsible for approximately 50% of tuberculosis (TB) cases in Far East Asia and at least 25% of TB cases globally. Studies have revealed that the Beijing genotype family i...

Full description

Bibliographic Details
Main Authors: Monika Kozińska, Marcin Skowroński, Paweł Gruszczyński, Ewa Augustynowicz-Kopeć
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/7/1699
_version_ 1797406789138907136
author Monika Kozińska
Marcin Skowroński
Paweł Gruszczyński
Ewa Augustynowicz-Kopeć
author_facet Monika Kozińska
Marcin Skowroński
Paweł Gruszczyński
Ewa Augustynowicz-Kopeć
author_sort Monika Kozińska
collection DOAJ
description The Beijing/W genotype is one of the major molecular families of <i>Mycobacterium tuberculosis</i> complex (MTBC), responsible for approximately 50% of tuberculosis (TB) cases in Far East Asia and at least 25% of TB cases globally. Studies have revealed that the Beijing genotype family is associated with a more severe clinical course of TB, increased ability to spread compared to other genotypes, and an unpredictable response to treatment. Based on the profile of spacers 35–43 in the Direct Repeat (DR) locus of the MTBC genome determined by spoligotyping, classical (typical) and modern (Beijing-like) clones can be identified within the Beijing family. While the modern and ancient Beijing strains appear to be closely related at the genetic level, there are marked differences in their drug resistance, as well as their ability to spread and cause disease. This paper presents two cases of drug-resistant tuberculosis caused by rare mycobacteria from the Beijing family: the Beijing 265 and Beijing 541 subtypes. The genotypes of isolated strains were linked with the clinical course of TB, and an attempt was made to initially assess whether the Beijing subtype can determine treatment outcomes in patients.
first_indexed 2024-03-09T03:31:42Z
format Article
id doaj.art-a61280cb1c9549cc9d9486f6a8cca77d
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T03:31:42Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-a61280cb1c9549cc9d9486f6a8cca77d2023-12-03T14:55:06ZengMDPI AGDiagnostics2075-44182022-07-01127169910.3390/diagnostics12071699Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB CasesMonika Kozińska0Marcin Skowroński1Paweł Gruszczyński2Ewa Augustynowicz-Kopeć3Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, PolandWielkopolska Pulmonology and Thoracic Surgery Centre of Eugenia and Janusz Zeyland, Szamarzewskiego 62, 60-569 Poznań, PolandWielkopolska Pulmonology and Thoracic Surgery Centre of Eugenia and Janusz Zeyland, Szamarzewskiego 62, 60-569 Poznań, PolandDepartment of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, PolandThe Beijing/W genotype is one of the major molecular families of <i>Mycobacterium tuberculosis</i> complex (MTBC), responsible for approximately 50% of tuberculosis (TB) cases in Far East Asia and at least 25% of TB cases globally. Studies have revealed that the Beijing genotype family is associated with a more severe clinical course of TB, increased ability to spread compared to other genotypes, and an unpredictable response to treatment. Based on the profile of spacers 35–43 in the Direct Repeat (DR) locus of the MTBC genome determined by spoligotyping, classical (typical) and modern (Beijing-like) clones can be identified within the Beijing family. While the modern and ancient Beijing strains appear to be closely related at the genetic level, there are marked differences in their drug resistance, as well as their ability to spread and cause disease. This paper presents two cases of drug-resistant tuberculosis caused by rare mycobacteria from the Beijing family: the Beijing 265 and Beijing 541 subtypes. The genotypes of isolated strains were linked with the clinical course of TB, and an attempt was made to initially assess whether the Beijing subtype can determine treatment outcomes in patients.https://www.mdpi.com/2075-4418/12/7/1699tuberculosisdrug resistance<i>Mycobacterium tuberculosis</i>Beijing-TBBeijing-like genotype
spellingShingle Monika Kozińska
Marcin Skowroński
Paweł Gruszczyński
Ewa Augustynowicz-Kopeć
Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
Diagnostics
tuberculosis
drug resistance
<i>Mycobacterium tuberculosis</i>
Beijing-TB
Beijing-like genotype
title Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
title_full Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
title_fullStr Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
title_full_unstemmed Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
title_short Multidrug-Resistant Tuberculosis—Diagnostic Procedures and Treatment of Two Beijing-like TB Cases
title_sort multidrug resistant tuberculosis diagnostic procedures and treatment of two beijing like tb cases
topic tuberculosis
drug resistance
<i>Mycobacterium tuberculosis</i>
Beijing-TB
Beijing-like genotype
url https://www.mdpi.com/2075-4418/12/7/1699
work_keys_str_mv AT monikakozinska multidrugresistanttuberculosisdiagnosticproceduresandtreatmentoftwobeijingliketbcases
AT marcinskowronski multidrugresistanttuberculosisdiagnosticproceduresandtreatmentoftwobeijingliketbcases
AT pawełgruszczynski multidrugresistanttuberculosisdiagnosticproceduresandtreatmentoftwobeijingliketbcases
AT ewaaugustynowiczkopec multidrugresistanttuberculosisdiagnosticproceduresandtreatmentoftwobeijingliketbcases